According to an official announcement released by Metaplanet Inc. on April 24, the Tokyo Stock Exchange-listed company Metaplanet announced the issuance of its 20th tranche of unsecured ordinary bonds, with a total issuance amount of 8 billion yen (approximately 50 million US dollars). EVO FUND will subscribe for the full amount, and the funds raised will be used to purchase Bitcoin (BTC).

Metaplanet announced that it will finance the EVO fund with 8 billion yen in interest-free bonds. All of the funds will be used to purchase Bitcoin, and about 1.2 billion yen of idle funds will be reallocated to increase holdings. The company currently holds 40,177 bitcoins, making it the third-largest reserve, but mNAV has fallen to 0.87, making it harder to buy more Bitcoin by issuing additional shares. EVO is a fund controlled by Michael Allerichi, a U.S. investor, and it is skilled at profiting through arbitrage-style trading of share warrants. Although this time there are no interest payments, it is effectively expected to dilute shareholders through future warrant exercises.

Bloomberg reported that U.S. investor Michael Lerch and his EVO fund focus on providing liquidity to cash-strapped small and mid-sized businesses, mainly through floating strike warrants. EVO holds a dominant position in the Japanese market, but its financing tools also face the risk of equity dilution. Metaplanet and EVO partnered and pivoted into a Bitcoin reserve company; however, its increased stock price volatility and reliance on funding have heightened operational uncertainty.

Tether’s frontier technology arm has taken a prominent spot on the global stage for brain-computer interface research, with its Tether EVO team finishing twice in the top five of the Brain-to-Text ’25 competition, including a hard-won fourth place, out of 466 participants. Tether said the results sh

A team from Stanford University has designed a complete bacteriophage using AI, bringing new developments in the fight against antibiotic-resistant bacteria, but also raising new issues in biosafety regulation. (Background: China has launched a fully robot-operated grocery store, is science fiction becoming reality or just a gimmick?) (Additional context: Bill Gates: AI will replace humans in 10 years, working two days a week is not a dream, three professions may survive) AI algorithms are accelerating into the depths of the laboratory. A research team from Stanford University published their latest results on bioRxiv last week: using an AI model named Evo, they designed a complete bacteriophage that is more infectious than similar viruses in nature and can precisely target antibiotic-resistant E. coli. This is the first time artificial intelligence has created a functional virus at the genomic level, marking a new world where technology expands from "generating text" to "generating life," delivering a shocking impact on the medical system and the Capital Market.

Kazakhstan plans to collaborate with giants like Solana and Mastercard to jointly launch a new stablecoin called "Evo" (KZTE), which will be pegged to Kazakhstan's national currency, the Tenge. This initiative aims to create a comprehensive local Web3 industry ecosystem and promote the integration of TradFi and the digital economy. Previously, Kazakhstan's Central Bank Digital Currency (CBDC) plan had stalled, and this strong partnership with private institutions may open up new pathways for the country's development in the Web3 space.

A Japanese listed company, Metaplanet, which once saw its stock price rise by 400% due to a frenzied purchase of Bitcoin, has fallen into crisis, with its stock price plummeting 54% since mid-June, resulting in more than half of its market capitalization evaporating. The company urgently launched a $3.8 billion preferred stock financing plan, intending to continue increasing its Bitcoin holdings. The "flywheel financing" mechanism originally in cooperation with Evo Fund has stalled due to the stock price crash. Eric Trump, the son of U.S. President Trump, will personally attend the special shareholders' meeting in Tokyo on September 5 to participate in the vote.